Hayashi-Takagi, A. | Search bioRxiv

bioRxiv2025

Human-specific fast synaptic kinetics enable rapid detection of predictive features

Humans can discern the underlying principles in complex environments, but the cellular basis of this ability is unclear. By comparing layer 2/3 cortical pyramidal neurons in five mammals (mouse, rat, marmoset, macaque and human), we found that human neurons exhibited distinctively faster kinetics of excitatory synaptic transmissions. In a computational model, neurons with human-type synapses detected hidden patterns more quickly in noise, and this superiority was only evident in unsupervised learning. Tracking synaptic weights revealed that human synapses were potentiated sharply and persistently by the patterns, while macaque-type synapses were broadly potentiated, which were easily eroded. These data suggest that the human-specific acceleration of synaptic kinetics enables the rapid extraction of latent structures in complex environments, providing a cellular basis for our efficient cognitive abilities.

neuroscience↗

bioRxiv2019

Investigation of betaine as a novel psychotherapeutic for schizophrenia

Betaine is known to act against various biological stresses and its levels were reported to be decreased in schizophrenia patients. Using Chdh (a gene for betaine synthesis)-deficient mice and betaine-supplemented inbred mice, we assessed the role of betaine in psychiatric pathophysiology, and its potential as a novel psychotherapeutic, by leveraging metabolomics, behavioral-, transcriptomics and DNA methylation analyses. The Chdh-deficient mice revealed remnants of psychiatric behaviors along with schizophrenia-related molecular perturbations. Betaine supplementation elicited genetic background-dependent improvement in cognitive performance, and suppressed methamphetamine (MAP)-induced behavioral sensitization. Furthermore, betaine rectified the altered antioxidative and proinflammatory responses induced by MAP and in vitro phencyclidine treatments. Notably, betaine levels were decreased in the postmortem brains from schizophrenia, and a coexisting elevated carbonyl stress, a form of oxidative stress, demarcated a subset of schizophrenia with \"betaine deficit-oxidative stress pathology\". We revealed the decrease of betaine levels in glyoxylase 1 (GLO1)-deficient hiPSCs, which shows elevated carbonyl stress, and the efficacy of betaine in alleviating it, thus supporting a causal link between betaine and oxidative stress conditions. Furthermore, a CHDH variant, rs35518479, was identified as a cis-expression quantitative trait locus (QTL) for CHDH expression in postmortem brains from schizophrenia, allowing genotype-based stratification of schizophrenia patients for betaine efficacy. In conclusion, the present study underscores the potential benefit of betaine in a subset of schizophrenia.

neuroscience↗